Search

everythinglearnresearchcommunity

for

Search:↓

Treating classic 21-hydroxylase deficiency requires precise glucocorticoid dosing and attention to individual patient needs, with new treatments showing promise.

Immunotherapy for cancer caused a patient to develop a condition affecting hormone production, requiring ongoing hormone replacement therapy.

A woman with ectopic Cushing's syndrome and COVID-19 passed away despite treatment.

A 21-year-old male with a rare genetic disorder experienced sudden hair loss and high DHEAS levels, likely due to a condition similar to PCOS, usually seen in women.

Rosella C. believes an earlier diagnosis of Cushing disease could have prevented severe symptoms.

Low testosterone does not prevent prostate cancer in men with type 1 diabetes.

A woman's rare ovarian tumor was treated with surgery, which stopped her symptoms and normalized her hormone levels.

A woman's severe hormone imbalance after menopause led to finding a rare ovarian tumor, treated by surgery.

Female hyperandrogenism is a condition caused by too much male hormones, leading to skin issues and ovulation problems, often due to Polycystic Ovary Syndrome, and is treated based on individual symptoms.

An ovarian tumor caused a woman's male-like symptoms, which improved after surgery.

The conclusion is that hirsutism in women can be managed with hair removal techniques, medications, and topical treatments.

A woman's severe male-like symptoms were caused by a rare, benign tumor in her ovary that produced male hormones.

The case showed the need for quick investigation of virilization in women and how emotional health is linked to physical health.

A patient with HAIR-AN syndrome, PCOS, and Hashimoto's thyroiditis improved with early diagnosis and treatment to prevent serious health problems.

Prostate cancer risk is not linked to blood testosterone levels.

The document concludes that hair loss in women can be treated with topical treatments or hormone therapy depending on the cause.

Hirsutism, often caused by PCOS, is treated with medication and weight loss is important for obese women with PCOS.

Testosterone therapy can help postmenopausal women with low sexual desire but needs more safety research and should be used with estrogen therapy.

After chemotherapy for a gestational trophoblastic tumor, normal pregnancy rates are possible, but there's a slightly higher risk of the tumor reoccurring in future pregnancies.

Hair growth issues can be linked to genetics, diseases, or medications, and new treatments are being developed.

Hirsutism, excessive hair growth in women, often caused by high androgen levels and polycystic ovary syndrome, can be treated with medication and weight management.

Hirsutism, excessive male-pattern hair in women, can be caused by high androgens or skin sensitivity, diagnosed by testosterone levels, and treated with hair removal and hormone therapy.

Cimetidine is not a first-choice treatment for female hair loss, and there's no consistently successful treatment for this condition in men or normal hormone level women.

Norethisterone (jenapharm) therapy is effective for endometrial cancer.

The patient had complex urinary tract issues and ambiguous genitalia, with physical features suggesting a hormonal imbalance.

Finasteride may cause sexual dysfunction by reducing epinephrine levels.

Early treatment of Female Pattern Hair Loss is important to stop it from getting worse, and various treatments can help, especially in mild to moderate cases.

Hair loss is mainly due to genes and hormones, and can be treated with minoxidil and finasteride. Excessive hair growth is linked to certain disorders and can be managed with hormonal therapy and laser hair removal.

Hormonal differences affect male pattern baldness.

Most women referred for excess male hormone symptoms had polycystic ovary syndrome (PCOS), with other conditions being less common.